Want a rapid, cost-effective way to screen your cancer therapies in vitro?
In this webinar, discover a new platform that combines a diverse panel of genomically annotated patient-derived tumors and 3D hydrogel patterning technology to recreate an environment of tumor, fibroblast and immune cells. Learn how the 3D modeling system allows you to target different components of the tumor microenvironment and assess your candidate’s efficacy alone or in combination with other therapies in vitro for better prediction of performance in the clinic.
Julia Schueler, PhD
Kolin Hribar, PhD
Founder and CEO
We are providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.